Women's Center/University IVF

Shawky Z Badawy, MD

Shawky Z Badawy, MD
Appointed 06/30/72
Women's Health Network
3 W T Crouse Hospital
736 Irving Ave.
Syracuse, NY 13210

315 470-7905

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Obstetrics and Gynecology: Reproductive Endocrinology and Infertility
  • Women's Health Network: Obstetric, Gynecology & Urogynecology, Pelvic Health

Research Programs and Affiliations

  • Obstetrics and Gynecology


Education & Fellowships

  • Residency: University Hospital, SUNY Health Science Center at Syracuse
  • Fellowship: Rockefeller University, 1970, Reproductive Endocrinology and Physiology
  • MD: Ain Shams University, Cairo, Egypt, 1958

Clinical Interests

  • Endometriosis, infertility management, menstrual dysfunction, laparoscopic and hysteroscopic surgery, and microsurgery.

Research Interests

  • Endometriosis, infertility management, menstrual dysfunction, laparoscopic and hysteroscopic surgery, and microsurgery.

Specialties & Certification

  • Reproductive Endocrinology and Infertility
  • Obstetrics and Gynecology

Diseases & Conditions Treated

  • Endometriosis
  • Infertility
  • Menopause
  • Polycystic Ovary Syndrome


  • Adults and Children


  • Gynecologic Laparoscopic Surgery
  • Hysterectomy
  • In Vitro Fertilization (IVF)
  • Infertility Testing


  • American College of Surgeons (ACS), Fellow
  • American Society for Reproductive Medicine (ASRM), Member
  • Royal Society of Medicine, Fellow
  • American Congress of Obstetricians and Gynecologists (ACOG), Fellow
  • Society for Reproductive Endocrinology and Infertility (SREI), Member
  • Society of Reproductive Surgeons (SRS), Member
  • North American Society for Pediatric and Adolescent Gynecology (NASPAG), Member
  • North American Menopause Society (NAMS), Member

Current Hospital Privileges

  • Upstate University Hospital
  • VA Medical Center
  • Crouse Hospital
  • St. Joseph's Hospital Health Center

Languages Spoken (Other Than English)

  • Arabic

HealthLinkOnAir Radio Interview

2/26/15 Mothers who suffer miscarriage need medical, emotional care

2/26/15 Should menopausal women treat hot flashes with hormones?

5/13/12 New techniques for preserving eggs for invitro fertilization


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Effect of Ovarian Steroids and Transforming Growth Factor Beta 1 on the Growth and Proliferation of Endometrioma Cells in Culture. With J. Holland, V. Cuenca

Endometriomas are cystic benign tumors which occur in the ovaries of women during reproductive years. Their development is initiated with ovarian steroids. However, suppression of ovarian steroids with GNRH agonist does not have an effect on the regression of these tumors. The thesis of the research is to grow the endometrioma cells in culture, to study the estrogen and progesterone receptor expression of these cells, to study the effect of various concentrations of estrogens and progesterone and transforming growth factor beta 1 on the growth and proliferation of these cells in culture. Transforming growth factor beta 1 is produced by macrophages. These macrophages have been found to be in excess in the peritoneal fluid as well as in the wall of endometriomas. This work will explain some of the factors which are involved in the development and growth of endometriomas.

Effect of Chocolate Cyst Fluid on Endometrioma Cells in Culture. With J. Holland, V. Cuenca

In this project the endometrioma cyst fluid is obtained during surgery and centrifuged to separate the supernatant fluid. It is evaluated in several ways:

  1. The effect of this fluid on growth and proliferation of endometrioma cells in culture;
  2. The contents of this fluid, specifically transforming growth factor beta 1, various interleukins, and ovarian steroids.

This will evaluate secretory functions of the endometrioma cells and the effect of those hormones and cytokines on the development and progress of endometriomas.

Effect of Pregnancy on the Natural History of Prolactin Secreting Pituitary Tumors.

Prolactin secreting pituitary tumors are considered to be the most common pituitary tumors. They are classified into microadenomas and macroadenomas. During the pregnancy there is a chance of about 5%-25% growth of the tumor. After delivery some of these tumors might remain the same size or they might regress or disappear. The natural history of this process is not known. The nature of this study is to evaluate the CT scans and MRIs of patients with prolactin-secreting pituitary tumors before and after delivery.

Selected References

Badawy, S., J. Holland, S. Landas, L. Frankel, V. Cuenca and S. Khan: The role of estradiol, progesterone, and transforming growth factor on human endometrioma cell culture. American Journal of Reproductive Immunology 36:58-63, 1996.


List of Publications

Clinical Profile Shortcut: http://www.upstate.edu/findadoc/badawys
Faculty Profile Shortcut: http://www.upstate.edu/faculty/badawys